Diversified Trust CO Bristol Myers Squibb CO Transaction History
Diversified Trust CO
- $3.23 Billion
- Q1 2025
A detailed history of Diversified Trust CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Diversified Trust CO holds 55,658 shares of BMY stock, worth $2.67 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
55,658
Previous 46,155
20.59%
Holding current value
$2.67 Million
Previous $2.61 Million
30.04%
% of portfolio
0.1%
Previous 0.08%
Shares
31 transactions
Others Institutions Holding BMY
# of Institutions
2,784Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$9.1 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.6 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$4.6 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$4.56 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$2.89 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $102B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...